SKLB 610 structure
|
Common Name | SKLB 610 | ||
---|---|---|---|---|
CAS Number | 1125780-41-7 | Molecular Weight | 415.365 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 500.9±50.0 °C at 760 mmHg | |
Molecular Formula | C21H16F3N3O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 256.8±30.1 °C |
Use of SKLB 610SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR at rate of 97%, 65% and 55%, respectively, at concentration of 10 μM in biochemical kinase assays. |
Name | N-Methyl-4-(4-{[3-(trifluoromethyl)benzoyl]amino}phenoxy)-2-pyridinecarboxamide |
---|---|
Synonym | More Synonyms |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 500.9±50.0 °C at 760 mmHg |
Molecular Formula | C21H16F3N3O3 |
Molecular Weight | 415.365 |
Flash Point | 256.8±30.1 °C |
Exact Mass | 415.114380 |
LogP | 3.49 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Index of Refraction | 1.595 |
Storage condition | -20℃ |
2-Pyridinecarboxamide, N-methyl-4-[4-[[3-(trifluoromethyl)benzoyl]amino]phenoxy]- |
N-Methyl-4-(4-{[3-(trifluoromethyl)benzoyl]amino}phenoxy)-2-pyridinecarboxamide |
SKLB 610 |
SKLB610 |